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RATES OF PLASMA PORPHYRIN DISAPPEARANCE IN FLUORESCENT VS. 
RED INCANDESCENT LIGHT EXPOSURE 
MAUREEN B. PoH-FITZPATRICK, M .D., AND VINCENT A. DELEo, M.D. 
Department of Dermatology, Columbia University College of Physicians and Surgeons, 
N ew York, New York, U.S.A. 
The rates of porphyrin disappearance in plasma specimens were assessed during exposure 
to standard fluorescent room lighting. Protoporphyrin half-life in specimens from patients 
with erythropoietic protoporphyria appeared to be less than 30 min under these conditions. 
Uroporphyrin-coproporphyrin mixtures in plasmas of patients with porphyria cutanea 
tarda were more photostable, with half-lives measurable in terms of hours. All plasma 
porphyrins could be protected for several days from similar photodegradation by performing 
all blood drawing, processing, and assay procedures under ordinary red-incandescent 
illumination, and by storage in the dark. 
Current concepts for the pathogenesis of photo-
toxic cutaneous reactions in patients with eryth-
ropoietic protoporphyria (EPP) imply circulation 
of excess protoporphyrin (PP) in blood plasma. 
Nevertheless, many plasma PP values within nor-
mal limits have been reported in blood from symp-
tomatic patients with EPP [1,2]. Delay times and 
storage conditions prior to assay of plasma speci-
mens for porphyrin content are often not stated in 
these reports . Instability of protoporphyrin in var-
ious solutions to light exposure is well known [3-
5]. Porphyrins absorb light maximally in regions 
of the electromagnetic spectrum which pass 
through ordinary window glass and laboratory 
glassware. These wavelengths (near 400 nm) are 
abundant in natural sunlight and present in flu-
orescent room lighting. In one report noting that 
efforts were made to avoid such light exposure 
during assay procedures, PP values were uni-
formly abnormal, although often low ( < 5 ~-tg/dl) 
[3]. Redeker, Brownow, and Sterling noted "high 
values" for plasma PP in all 4 patients with EPP 
they reported, but no details of light exposure, 
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assay techniques, or numerical data were given 
[6]. Van Gog and Schothorst noted a > 90° loss of 
measurable PP in plasma of an EPP patient kept 
for 2 hr without light protection, as well as PP 
decline in plasma kept refrigeralted or frozen in 
the dark [3]. Schlenker, Davis, and Kitchell re-
ported diminution of plasma uroporphyrins and 
coproporphyrins stored up to 96 hr at room temper-
ature, but did not note light exposure conditions 
[7]. 
We have done studies to more closely determine 
rates of porphyrin disappearance in plasma speci-
mens not rigorously protected from ambient light. 
We also wished to determine if spuriously low 
values possibly resulting from inadvertent light 
exposure of specimens during blood collection, 
transport, and storage procedures could be easily 
avoided. 
A rapid quantitative fluorometric assay for por-
phyrins in minute quantities of red blood cells [8] 
recently adapted to use in blood of patients with 
EPP [9] was modified for use in quantitative assay 
of plasma porphyrins. This rapid micromethod 
allowed frequent determinations to closely follow 
porphyrin disappearance from porphyric plasma 
specimens exposed to our standard laboratory flu-
orescent lighting compared with specimens kept 
in the dark and completely processed under red-
incandescent illumination. Effects of several stor-
age temperatures on plasma porphyrin stability 
were also investigated. 
METHODS 
Blood was obtained by venipuncture from sympto-
matic patients with EPP or porphyria cutanea tarda 
(PCT) in tubes containing a trace of heparin. In plas-
mas from patients with EPP the porphyrin is spectrally 
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identical with protoporphyrin; in plasmas from patients 
with PCT spectral studies suggest mixtures ofuro- and 
coproporphyrins [10]. Plasma was immediately sepa-
rated from cells by centrifugation for 5 min at 2700 
rpm without cooling. Plasmas were removed and trans-
ferred to separate tubes to preclude hemolytic contam-
ination by intracellular porphyrins. Each plasma spec-
imen was divided into several aliquots for storage in 
glass tubes with tightly-sealing screw tops. Pairs of 
these sealed specimens were then maintained at 4°, 28° 
and 37°C. One of each pair was continuously exposed 
to the standard fluorescent lighting in the laboratory: 
6. banks of 4 Durotest cool-white lamps behind plastic 
diffusion panels. Radiance intensity at 405 nm from 
these lamps was measured by a International Light 
Co. IL600A research photometer to be - 7.2 1Lw/cm2 at 
bench level. The second paired aliquot was kept in the 
dark except during procedures. All blood drawing, 
processing, and porphyrin assay techniques were car-
ried out in red incandescent illumination: 4, 25-w 
General Electric red incandescent bulbs. Bench level 
radiance at 405 nm from these red lamps measured 
only - 4.5 x 10- 3 ILW/cm2. Sterile technique was used 
wherever possible, but was not unbroken. 
Immediately after each plasma specimen was sepa-
rated from the cells plasma porphyrin content was 
determined in triplicate. The average value was as-
sumed to represent 100% porphyrin content at time 
zero. Minute quantities of each of the paired, sealed 
aliquots were subsequently removed for similar assay 
in duplicate at variable time intervals from 5 min to 
several days during storage varying as described above 
(see Figures) . 
Porphyrin assay was accomplished by a modification 
of previously described techniques [8,9]. Briefly, 100 ILl 
of plasma was added to 0.2 ILl of a mixture of 5% Celite 
in phosphate buffered saline (pH 7.4) in a test tube. 
Two ml of a 4:1 mixture (v:v) of ethyl acetate:acetic 
acid was added to the tube and the contents vortexed 
for 10 sec. After a 30 sec centrifugation at 2000 rpm , 
the clear supernatant was completely decanted into 
another test tube containing 2 ml of 1.5 N HCl. After a 
10 sec vortexing, 2 phases separated with the bulk of 
the. porphyrin in the lower acid layer. Fluorescence of 
the acid layer was measured as previously described, 
compared with the fluorescence of a standard solution 
of coproporphyrin I, 0.05 ILg/ml in 1.5 N HCl. Subse-
quent calculations included appropriate correction fac-
tors to accommodate the different relative fluorescence 
intensities of equivalent ILg quantities of proto-and 
uroporphyrin in ethyl acetate-saturated 1.5 N HCl 
compared to the coproporphyrin standard. 
Exhaustive reextraction of 30 Celite sediments and 
of several ethyl acetate layers (both from plasmas of 
EPP and PCT) yielded 10 ± 2% additional porphyrin 
recovery. Therefore - 90% of plasma porphyrin extract-
able by this method appeared readily obtainable with 1 
pass. Only 1 pass was performed in assays for this 
study; reported values are not corrected for incomplete 
recovery . 
Calculations of quantitative plasma PP content were 
performed as previously described [9], modified for the 
larger original plasma volume assayed. 
Calculations of quantitative plasma porphyrin con-
tent in specimens containing predominantly mixtures 
of 4 to 8 carboxyl porphyrins were performed assuming 
a 100% uroporphyrin content. The "total porphyrin" 
value thus obtained, although not rigorously quantita-
tive, was adequate to the course of these experiments , 
since the "total porphyrin" value at time zero was 
assumed to be 100% and subsequent values were com-
pared in terms of percentage of original value. 
Plasma specimens from 20 patients with EPP were 
then drawn , processed, and assayed for PP using the 
red illumination only. Data thus obtained was com-
pared with those of previously reported studies. 
Values for plasma porphyrins determined in 60 spec-
imens from patients with other dermatologic disorders 
and normal individuals ranged from 0.0 to 0.9 fLg/dl ex 
= 0.2, SD = 0.09). 
RESULTS 
All plasma specimens exposed to fluorescent 
light showed marked changes in measurable por-
phyrin compared with the paired specimens stored 
in the dark. Specimens stored in the dark retained 
measurable porphyrin content near 100% of origi-
nal values in all cases, whether from patients 
with EPP or PCT, and at all temperatures tested, 
for as long as 3 wk. 
All plasma specimens from patients with EPP 
showed rapid decline in measurable PP under our 
ordinary laboratory fluorescent light (Fig 1). The 
half-life (T 1/2) was so short that it was impossible 
to discern any difference among the temperatures 
tested. In 4 specimens where frequent measure-
ments were made during the first 2 hours of 
fluorescent light exposure, the T 1/2 was less than 
30 min, and as little as 6 min (Fig 1). 
Although 4 plasma specimens from patients 
with PCT showed a similar decline in measurable 
total porphyrin with continuing fluorescent light 
exposure, the rate of decline was much slower 
than that observed in plasmas containing proto-
porphyrin. The T 1/2 for these porphyrin mixtures 
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FIG 1. Protoporphyrin disappearance from 4 different 
erythropoietic protoporphyria plasmas in dark storage 
vs. laboratory flum·escent lighting exposure. 28°C. 
Open symbols represent light- exposed specimens. 
Closed symbols represent paired, dark- stored speci-
mens. Original values: 0, 45 ILg/dl; i< , 12.5 ILg/dl; 0, 
30 ILg/dl; 6.' 19 ILg/dl. 
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FIG 2. Porphyrin disappearance from 4 different 
porphyria cutanea tarda plasmas in dark storage vs. 
laboratory fluorescent lighting. 28°C. Open symbols 
represent light-exposed specimens. Closed symbols rep-
resent paired, dark- stored specimens. Original values 
("total porphyrin"): 0, 5.4 ~-tg/dl; 1:l , 3.3 ~-tg/dl; 0, 11.9 
!Lg!dl; !:::, , 3.6 ~-tg/dl. 
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FIG 3. Plasma protop_orphyrin in blood of 20 sympto-
matic patients with erythropoietic protoporphyria de-
termined with rigorous protection from inadvertent 
light exposure during blood drawing, transport, and 
assay procedures, compared with several series re-
ported previously. Low or normal values may have 
resulted from even brief exposures of specimens to 
standard fluorescent room lighting. 
was measurable in terms of hours rather than 
minutes (Fig 2). We were not able to appreciate 
any significant difference in rate of decline of 
porphyrins in PCT plasmas with variable temper-
atures tested. 
Quantitative data for PP concentration in 
plasma specimens from 20 symptomatic patients 
with EPP, obtained and assayed under red incan-
descent illumination as described, are shown in 
Fig 3. These data, uncorrected for incomplete 
recovery, are compared with data reported in 
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other series (including data adjusted upward in 
one series for recovery of 60% [3]). Significant 
observations are the absence of any normal values 
(< 1 J.Lg/dl) and uniformly high values ex = 42, 
range 11-100 J.Lg/dl) for plasma PP in this popula-
tion. 
DISCUSSION 
The type of lighting present in our laboratory is 
similar to that in many clinical and laboratory 
areas. It is clear that the present data confirm 
and expand observations of prior investigators 
regarding photolability of plasma porphyrins and 
that even very brief exposures of plasma speci-
mens containing increased porphyrins, especially 
those with PP, to ambient light may result in 
significant loss. 
It appears advisable that plasma specimens 
from porphyric patients be collected, transported, 
and otherwise processed with due caution against 
inadvertent and prolonged exposure to the fluores-
cent light usually abundant in patient care and 
laboratory facilities. Properly light-protected spec-
imens will, even after several days' refrigerated 
storage, yield close to 100% of original measurable 
porphyrin content. 
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